Janssen Pharmaceuticals has signed a collaboration agreement with the National Taiwan University (NTU) and the university’s hospital (NTUH) to cooperate on developing new drugs for treating hepatitis B. Despite the high success rate of viral suppression achieved by existing medications, the virus is currently incurable.
Chen Ding-shinn (陳定信), chair professor at National Taiwan University Medical College, said that there are more than 350 million people in the world infected with the hepatitis B virus (HBV), 60 to 70 percent of which are in Asia.
Every year, more than 600 thousand people die as a result of complications such as liver cirrhosis and liver cancer caused by the virus.
“HBV can be transmitted prenatally [from mother to child] or by having contact with an infected person. While less than 3 percent of adults infected with the virus develop chronic hepatitis, more than 90 percent of infected newborns do,” Chen said. “Those who have chronic or persistent hepatitis B are at a high risk of developing liver cirrhosis or liver cancer later in life.”
There are about 2.4 million HBV carriers in Taiwan, Chen said, adding that statistics in 2011 showed that deaths attributable to liver cancer ranked No. 2 on the list of leading causes of death for men and women.
“Eighty percent to 90 percent of liver cancer patients had chronic hepatitis B,” he said.
“However, after Taiwan started vaccinating newborns against HBV in 1984, the number of yearly infections has decreased,” Chen said.
While the nation’s vaccination plan is an effective prevention measure, “having better control over the source of infection is still out of reach. Interferon, an approved medication for treating HBV infections is effective in only one-third of patients, while another treatment, nucleoside analogue therapy, inhibits viral replication without completely eliminating the virus.”
The collaboration is intended to develop a treatment to tackle the disease, Jansen, NTU and NTUH said in a joint statement.
Chen Pei-jer (陳培哲), a professor at the Graduate Institute of Clinical Medicine in NTUH’s Medical College and the principal investigator of the collaboration, said the aim is to “accelerate the development of a new hepatitis B drug by combining the resources uniquely held by the respective partners.”
“NTU has been working in this research field for more than 50 years. NTU’s specialization and experience makes it peerless in the fields of drug research and development,” Chen Pei-jer said.
“Janssen has a large collection of compounds as drug candidates. They need a platform to see whether the candidates are safe and effective,” Chen Pei-jer added.
From the mouse model first established by the NTU research team for assaying anti-viral and immune-modulatory activity — an important indication of HBV eradication — and the woodchuck model, which demonstrates HBV activity most similar to that of human HBV, to recent clinical research, Taiwan has always been a leader in the field of HBV treatment, Chen Pei-jer said, adding that NTU’s research was “a complete line from bench to bedside and back.”
“We are aiming to take the lead in developing a new drug to fully eradicate HBV,” the lead investigator said.
US climber Alex Honnold is to attempt to scale Taipei 101 without a rope and harness in a live Netflix special on Jan. 24, the streaming platform announced on Wednesday. Accounting for the time difference, the two-hour broadcast of Honnold’s climb, called Skyscraper Live, is to air on Jan. 23 in the US, Netflix said in a statement. Honnold, 40, was the first person ever to free solo climb the 900m El Capitan rock formation in Yosemite National Park — a feat that was recorded and later made into the 2018 documentary film Free Solo. Netflix previewed Skyscraper Live in October, after videos
Starting on Jan. 1, YouBike riders must have insurance to use the service, and a six-month trial of NT$5 coupons under certain conditions would be implemented to balance bike shortages, a joint statement from transportation departments across Taipei, New Taipei City and Taoyuan announced yesterday. The rental bike system operator said that coupons would be offered to riders to rent bikes from full stations, for riders who take out an electric-assisted bike from a full station, and for riders who return a bike to an empty station. All riders with YouBike accounts are automatically eligible for the program, and each membership account
NUMBERS IMBALANCE: More than 4 million Taiwanese have visited China this year, while only about half a million Chinese have visited here Beijing has yet to respond to Taiwan’s requests for negotiation over matters related to the recovery of cross-strait tourism, the Tourism Administration said yesterday. Taiwan’s tourism authority issued the statement after Chinese-language daily the China Times reported yesterday that the government’s policy of banning group tours to China does not stop Taiwanese from visiting the country. As of October, more than 4.2 million had traveled to China this year, exceeding last year. Beijing estimated the number of Taiwanese tourists in China could reach 4.5 million this year. By contrast, only 500,000 Chinese tourists are expected in Taiwan, the report said. The report
Temperatures are forecast to drop steadily as a continental cold air mass moves across Taiwan, with some areas also likely to see heavy rainfall, the Central Weather Administration (CWA) said. From today through early tomorrow, a cold air mass would keep temperatures low across central and northern Taiwan, and the eastern half of Taiwan proper, with isolated brief showers forecast along Keelung’s north coast, Taipei and New Taipei City’s mountainous areas and eastern Taiwan, it said. Lows of 11°C to 15°C are forecast in central and northern Taiwan, Yilan County, and the outlying Kinmen and Lienchiang (Matsu) counties, and 14°C to 17°C
RSS